Industry Urges Caution Over Japan HTA Plans
This article was originally published in PharmAsia News
Executive Summary
Japan may have decided to dip an exploratory toe in the waters of health technology assessment, but the research-based pharma industry is continuing to voice early caution over potential shortcomings in methodology and expertise, and to stress the need for a holistic approach.